Research Highlights Freenome’s Blood Test for Colorectal Cancer to Primary Care Physicians

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Oct. 4, 2021 /PRNewswire/ -- Freenome, a privately held biotech company, presented at the American Association of Family Practitioners (AAFP) Family Medicine Experience virtual meeting last week. The poster1 describes the development of Freenome's multiomics blood test for the detection of early-stage...

Click to view original post